Exploring FDA-approved small molecules for their potential as PD-1/PD-L1 inhibitors: integrating computational screening with experimental testing
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
Computational Drug Discovery Methods
Melanoma and MAPK Pathways
Publication details
- Journal / source
- Journal of Molecular Modeling
- Publisher
- Springer Science and Business Media LLC
- Volume
- 32
- Issue
- 3
- Pages
- 65–65
- Publication date
- 11 February 2026
- Language
- EN